CME/CE: Anticoagulant Use Among Afib Patients Wanes Over Time
By: Alere Staff
American Heart Association
November 11, 2015 – November 11, 2017
Physicians: 0.25 AMA PRA Category 1 Credit(s) ™
Barely half of patients with atrial fibrillation who were prescribed rivaroxaban to prevent stroke remained on the treatment after two years, but their adherence was still better than Afib patients on warfarin or dabigatran. The study suggests that physicians have to address the common attitudes of patients who are taking drugs for chronic, asymptomatic diseases to help improve adherence.